| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/28/2005 | WO2004022589A9 Tumor tag and the use thereof |
| 04/28/2005 | WO2003099227A3 Modulation of ptp1b signal transduction by rna interference |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | WO2003087389A3 Biologic modulations with nanoparticles |
| 04/28/2005 | WO2003086276A3 Compositions and methods for portal specific gene delivery and treatment of infection |
| 04/28/2005 | WO2003084987A3 Polypeptides from bacteria and uses thereof |
| 04/28/2005 | WO2003073826A8 Novel compositions and methods for cancer |
| 04/28/2005 | WO2003068929A3 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2002101061A8 Method for obtaining a monocotyledon plant containing a gene of interest free of foreign ancillary sequence |
| 04/28/2005 | WO2002092768A3 Novel alanine transaminase enzyme and methods of use |
| 04/28/2005 | WO2002090497A3 Transgenic high tryptophan plants |
| 04/28/2005 | US20050091717 transgenic plant comprising in its genome a transgene encoding a member FLC gene family; flowering locus C family genes; having early timing of its flowering |
| 04/28/2005 | US20050091716 Novel plants and processes for obtaining them |
| 04/28/2005 | US20050091715 Cacao endoproteinases and production of cocoa flavor from same |
| 04/28/2005 | US20050091713 Nucleic acid nematicides |
| 04/28/2005 | US20050091711 isolated by identifying and analyzing genes of Arabidopsis thaliana; trichome is involved in secretion and excretion from the surface of a plant body |
| 04/28/2005 | US20050091710 a transposon-like element specifically present in the rye genome but not present in the wheat genome, for the purpose of breading wheat exhibiting resistance to disease and environmental stress |
| 04/28/2005 | US20050091709 Transgenic organism epressing fungal mrp-like abc transporters |
| 04/28/2005 | US20050091708 Nucleic acid compositions conferring altered metabolic characteristics |
| 04/28/2005 | US20050091707 Modification of lignin biosynthesis |
| 04/28/2005 | US20050091706 Recombinant viral switches for the control of gene expression in plants |
| 04/28/2005 | US20050091705 good for colds and coughs, indigestion, stomach pain and diarrhoea. Nausea, ulcers, ringworm and asthma can be effectively treated with Tulsi. It is said to lower blood sugar and increase lactation |
| 04/28/2005 | US20050091704 transgenic mouse in which the Ant2 gene is inactivated in the liver; thought to be an integral component of the mitochondrial permeability transition pore |
| 04/28/2005 | US20050091703 Nonhuman model animal of th2-mediated hyperimmune response |
| 04/28/2005 | US20050091702 Expression of polypeptides in rod outer segment membranes |
| 04/28/2005 | US20050090660 2'-deoxy-L-nucleosides |
| 04/28/2005 | US20050090658 Comprises polymorphic variations/point mutations linked to cation channel dysfunctions; genetic engineering; treansgenic animal; antibody |
| 04/28/2005 | US20050090657 Novel human proteases and polynucleotides encoding the same |
| 04/28/2005 | US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 04/28/2005 | US20050090644 Production of secreted polypeptides |
| 04/28/2005 | US20050090643 protein isolated from cyanobacteria, is known to have anti-viral activity |
| 04/28/2005 | US20050090641 miniblock polymers that can self-assemble into three-dimensional materials through liquid crystalline behavior |
| 04/28/2005 | US20050090465 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 04/28/2005 | US20050090464 Vectors for enhanced expression of Vegf for disease treatment |
| 04/28/2005 | US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 04/28/2005 | US20050090443 Biosynthesis inhibition of oestrogen in an oestrogen-dependent breast tumor by administering a antitumor biodrug, Sant 7; aromatase, oestrone sulphatase, or oestradiol dehydrogenase inhibitors |
| 04/28/2005 | US20050090442 administering peptides, polypeptides, proteins or mimetics which correspond to non-membrane associated form of the p75 neurotrophin receptor (p75NTR) death signal region; antiapoptosis |
| 04/28/2005 | US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models: |
| 04/28/2005 | US20050090440 Tumour treating combinations, compositions and methods |
| 04/28/2005 | US20050090435 nucleotide sequences, genetic vectors comprising and/or genes expressing the nucleotide sequences, use to transform plant cells to produce proteins or fragments of proteins used as anticarcinogenic agents |
| 04/28/2005 | US20050090010 New family of vectors capable of cloning nucleic acids of wide range size and preferably very long ones, with high efficiency of excision and reduced background and contamination; also provided are methods of cloning and for preparing bulk library using such vectors |
| 04/28/2005 | US20050090009 Compositions of stabilized DNA for coating microprojctions |
| 04/28/2005 | US20050090008 Controlled surface-associated delivery of genes and oligonucleotides |
| 04/28/2005 | US20050090007 To produce human proteins in economical yields and in a form which is suitable for the production of a pharmaceutical preparation |
| 04/28/2005 | US20050090003 Genetically-modified, non-human mammal, wherein the genome of the mammal comprises a genetic modification to a copy of the P2x7R gene that results in disrupted P2x7R gene function from the modified gene |
| 04/28/2005 | US20050090001 Cell lines and methods for producing proteins |
| 04/28/2005 | US20050090000 Novel human 7TM protein and polynucleotides encoding the same |
| 04/28/2005 | US20050089999 Method for the production and purification of adenoviral vectors |
| 04/28/2005 | US20050089986 Fermentation; Corynebacterium; for improving the fermentative production of said L-amino acids, particularly L-lysine |
| 04/28/2005 | US20050089985 Rescue of canine distemper virus from cdna |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |
| 04/28/2005 | US20050089983 Novel protein, genes encoding the same and method of using the same |
| 04/28/2005 | US20050089982 A hybrid polyketide synthase ("PKS") gene containing a first nucleic acid portion or portions encoding a domain of a first type I PKS, a second nucleic acid portion or portions encoding type I PKS domain which is heterologous to first PKS; Saccharopolyspora species or Streptomyces species as host cell |
| 04/28/2005 | US20050089981 Cucleic acid cotnaining a specific nucleotide sequence which encodes a polypeptide which elongates alpha -linolenic acid by two or more carbon atoms whereas gamma -lino-lenic is not elongated |
| 04/28/2005 | US20050089980 Novel laccase enzyme and the gene encoding the enzyme |
| 04/28/2005 | US20050089974 Fermentative production of d-hydroxyphenylglycine and d-phenylglycine |
| 04/28/2005 | US20050089973 Methods and microorganisms for production of panto-compounds |
| 04/28/2005 | US20050089971 Preparation of animal feed containing bacterioferrins and vitamin b5; fermenting at least one microorganism of the Enterobacteriaceae family under conditions suitable for the formation of the cysK gene product cysteine synthase A; site-directed mutagenesis |
| 04/28/2005 | US20050089969 exsulins have a molecular weight of up to 55,000 Daltons and have1 to 50 basic units of specific amino acids; therapeutic and dietetic use |
| 04/28/2005 | US20050089967 Mutant tyrosine repressor gene and utilization thereof |
| 04/28/2005 | US20050089966 Chemically modified enzymes with multiple charged variants |
| 04/28/2005 | US20050089965 Novel human secreted proteins and polynucleotides encoding the same |
| 04/28/2005 | US20050089963 Proteases from gram positive organisms |
| 04/28/2005 | US20050089962 Novel human ion channel proteins and polynucleotides encoding the same |
| 04/28/2005 | US20050089961 Class of alpha2delta calcium channel subunits |
| 04/28/2005 | US20050089960 Biosynthesis; immunoglobulin signal peptides; fusion proteins; for delivery to the central nervous system and eye by gene therapy; host cells |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089956 Via biosynthesis of proteins from Pasteurella |
| 04/28/2005 | US20050089955 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/28/2005 | US20050089954 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 04/28/2005 | US20050089950 Method for coarse purification of cell digests from microorganisms |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089938 For treatment of epilepsy, hypertension, angina pectoris, cerebral ischaemia, Parkinson's disease, insulin-dependent diabetes, and/or Lambert-Eaton myasthenic syndrome |
| 04/28/2005 | US20050089937 Morphine modulating peptide; opoid receptor modulators with effects on morphine analgesia tolerance and withdrawal; drug screening |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089925 43239, a novel GPCR-like molecule and uses thereof |
| 04/28/2005 | US20050089913 Compositions and methods for the identification and selection of nucleic acids and polypeptides |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089906 Haplotype estimation method |
| 04/28/2005 | US20050089905 Polymorphisms associated with ion-channel disease |
| 04/28/2005 | US20050089902 Methods and compositions for siRNA expression |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089892 Biiodrugs for diagnosis, drug screening, clinical trial monitoring, treatment of physiological disorders; viral disease and infection prevention; expression vectors |
| 04/28/2005 | US20050089888 Platelet glycoprotein Ib alpha variant fusion polypeptides and methods of use thereof |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089886 Host cell expression systems, proteins, fusion proteins, polypeptides and peptides, antibodies; genetically engineered animals; drug screening, diagnosis |
| 04/28/2005 | US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase |
| 04/28/2005 | US20050089882 Rhamnosyl-tranferase gene and uses thereof |
| 04/28/2005 | US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes |
| 04/28/2005 | US20050089879 DNA sequences coding for a Delta 5-desaturase, wherein the enzymatic activity is specific solely for dihomo-gamma-linolenic acid; transgenic plants |
| 04/28/2005 | US20050089872 Nucleic acid molecules encoding annexins from plants |
| 04/28/2005 | US20050089871 G protein-related kinase mutants in essential hypertension |
| 04/28/2005 | US20050089869 GlcNac phosphotransferase of the lysosomal targeting pathway |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089867 Antigen fragments for the diagnosis of toxoplasma gondii |
| 04/28/2005 | US20050089865 Delta 6 desaturases from primulaceae, expressing plants and pufa-containing oils |
| 04/28/2005 | US20050089864 Aptamer based fluorescent reporters that function based on a switch from DNA/DNA duplex conformation to DNA/target conformation; signal generated when there is a dissociation of the duplex structure which occurs in presence of a target |
| 04/28/2005 | US20050089862 Polymerase Chain Reaction (PCR); analyzing differential gene expression patterns; use e.g. for diagnosis of Alzheimer's disease; high throughput approach; determining the relative copy number of a group of target nucleic acid molecules present in a sample; preclinical noninvasive diagnosis |